- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Reaction Time in Hungary
Total 35 results
-
Semmelweis UniversityTerminatedChronic Heart Failure | Vitamin D Adverse ReactionHungary
-
Semmelweis University Heart and Vascular CenterNational Research, Development and Innovation Fund of Hungary, Project no...RecruitingMagnetic Resonance Imaging | Heart Transplant Failure and RejectionHungary
-
Eveliqure Biotechnologies GmbHCompletedGastrointestinal Disease | Reactive Arthritis | Diarrheal Disease, InfectiousHungary
-
University of PecsRecruitingWaiting Times, Patient Pathways, Effect of Lifestyle-related, Clinical and Demographic Parameters on OutcomesHungary
-
Szeged UniversityUnknownHealthy Subjects | COPD Patients | Semi-supine Echo (SSE) | Flow-mediated Vasodilatation (FMD) | High Sensitive C-reactive Protein (hsCRP)Hungary
-
Szeged UniversityRecruitingMesenchymal Stem Cells | Venous Leg Ulcer | Autologous Adipose Stromal Vascular Fraction | Adipose-Derived Mesenchymal Stem CellsHungary
-
Esperion Therapeutics, Inc.The Cleveland ClinicCompletedCardiovascular Diseases | Statin Adverse ReactionBelgium, Germany, United States, Austria, Estonia, Mexico, New Zealand, Spain, Russian Federation, Netherlands, Hungary, Australia, Denmark, South Africa, United Kingdom, Bulgaria, Argentina, Romania, Turkey, Croatia, Serbia, Canada, Lithuan... and more
-
Szeged UniversityRecruitingLeg Ulcer | Diabetic Foot Ulcer | Mesenchymal Stem Cells | Autologous Adipose Stromal Vascular Fraction | Adipose-Derived Mesenchymal Stem CellsHungary
-
SanofiRecruitingLung Transplant RejectionBelgium, Finland, Israel, Italy, Hungary, Spain, Netherlands, United States, France, Czechia
-
Hendrik StreeckJanssen, LPCompletedHIV Infections | Sexual Behavior | HIV-1-infection | Risk ReductionFrance, Hungary, Spain, Poland, Italy
-
Novartis PharmaceuticalsCompletedKidney Transplant RejectionUnited States, Hungary, Japan, United Kingdom, Belgium, Spain, Netherlands, Germany, Australia, France, Korea, Republic of, Switzerland, Norway, Italy, Latvia, Sweden, Argentina, Brazil, Canada, Czechia
-
Novartis PharmaceuticalsCompletedLiver Transplant RejectionUnited States, Belgium, Germany, Spain, Argentina, Netherlands, Italy, Hungary, France, Czechia
-
Ionis Pharmaceuticals, Inc.CompletedChronic Heart Failure With Reduced Ejection FractionUnited States, Hungary, Poland
-
CSL BehringICON Clinical ResearchTerminatedAntibody-mediated RejectionKorea, Republic of, United States, New Zealand, Spain, Taiwan, Netherlands, Australia, France, Canada, Belgium, Czechia, Hungary, Sweden, Austria, Germany
-
PfizerCompletedReduction of Hypertrophic Skin ScarringUnited States, Germany, Hungary, Spain
-
BayerMerck Sharp & Dohme LLCRecruitingChronic Heart Failure With Reduced Ejection FractionSpain, United States, Argentina, Hungary, Italy, Poland, Sweden
-
Novartis PharmaceuticalsCompletedPrevention of Acute Rejection in Paediatric Recipients of a Renal TransplantGermany, United Kingdom, France, Italy, United States, Hungary, Norway, Spain, Argentina, Brazil, Poland, Sweden, Turkey
-
CytokineticsCompletedHeart Failure With Reduced Ejection FractionUnited States, Hungary, France, Canada, Netherlands, Germany, Poland, Italy, Sweden
-
Novartis PharmaceuticalsCompletedHeart Failure With Reduced Ejection FractionHungary, Spain, Italy, United States, Germany, United Kingdom, Turkey, Slovakia, Bulgaria, Finland, Puerto Rico
-
ActelionChiltern International Ltd.; Medidata Solutions; Frontier Science & Technology... and other collaboratorsTerminatedHeart Failure With Preserved Ejection Fraction and Pulmonary Vascular DiseaseUnited States, United Kingdom, Israel, Austria, Russian Federation, Germany, Poland, Denmark, Argentina, Brazil, Bulgaria, France, Hungary, Romania, Sweden
-
AstraZenecaCompletedHeart Failure With Preserved Ejection FractionUnited States, France, Netherlands, Belgium, Taiwan, Slovakia, Japan, Czechia, Hungary, Australia, Bulgaria, Poland, Russian Federation, Brazil, Denmark, Turkey, Sweden, Canada
-
ActelionCompletedHeart Failure With Preserved Ejection FractionUnited States, Spain, United Kingdom, Poland, Germany, Israel, Austria, Czechia, Russian Federation, Denmark, Bulgaria, Hungary, France, Argentina, Brazil, Romania, Sweden
-
Eli Lilly and CompanyRecruitingHeart Failure | Heart Failure With Preserved Ejection FractionSpain, United States, Japan, United Kingdom, Czechia, Hungary, Israel, Brazil, Argentina, Canada, Poland, Turkey
-
Novartis PharmaceuticalsCompletedHeart Failure With Preserved Ejection FractionColombia, Romania, United States, Austria, Belgium, Estonia, Turkey, Germany, Netherlands, Italy, Spain, Thailand, Argentina, France, Bulgaria, Hungary, Israel, Peru, Lithuania, Guatemala, India, Russian Federation, Denmark, Mexico, Slo... and more
-
BayerMerck Sharp & Dohme LLC; Duke Clinical Research Institute; Canadian VIGOUR CentreCompletedChronic Heart Failure With Preserved Ejection FractionSpain, United States, Belgium, Singapore, Taiwan, Canada, Japan, Italy, Austria, Bulgaria, Germany, Greece, Israel, Poland, Portugal, Hungary, Russian Federation, Argentina, Colombia, Malaysia, South Africa
-
Novartis PharmaceuticalsCompletedHeart Failure With Preserved Ejection FractionChina, Germany, United States, Colombia, South Africa, Italy, Austria, Belgium, Croatia, Romania, Taiwan, Japan, Netherlands, Denmark, France, Israel, Spain, Switzerland, Korea, Republic of, Argentina, Canada, United Kingdom, Bulgaria, Gree... and more
-
AstraZenecaActive, not recruitingHeart Failure With Reduced Ejection Fraction | HyperkalaemiaUnited States, Spain, Canada, Brazil, Hungary, Czechia, Ukraine, Poland, United Kingdom
-
AstraZenecaCompletedHeart Failure With Preserved Ejection FractionUnited States, Canada, Belgium, Czechia, Hungary, Taiwan, Vietnam, Mexico, Peru, China, Japan, Bulgaria, Spain, Brazil, Saudi Arabia, Netherlands, Romania, Russian Federation, Poland, Argentina
-
Merck Sharp & Dohme LLCActive, not recruitingChronic Heart Failure With Reduced Ejection FractionChina, United States, Argentina, Australia, Austria, Brazil, Canada, Chile, Colombia, Czechia, Denmark, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Ireland, Israel, Italy, Korea, Republic of, Malaysia, Mexico, New Zealand, Peru and more
-
IpsenCompletedNeuroendocrine Tumors | Carcinoid SyndromeFrance, Italy, United Kingdom, Poland, Spain, Hungary, Czechia, Israel
-
Novartis PharmaceuticalsCompletedChronic Heart Failure With Reduced Ejection FractionIndia, Romania, Belgium, Czechia, Estonia, Hungary, Russian Federation, Taiwan, United Kingdom, Spain, Israel, Thailand, Canada, Korea, Republic of, United States, Bulgaria, Denmark, Netherlands, Philippines, Lithuania, Germany, T... and more
-
AstraZenecaCompletedChronic Heart Failure With Reduced Ejection Fraction (HFrEF)United States, Canada, Denmark, United Kingdom, Czechia, Vietnam, Germany, Brazil, India, China, Japan, Taiwan, Netherlands, Bulgaria, Slovakia, Hungary, Poland, Russian Federation, Argentina, Sweden
-
Novartis PharmaceuticalsTerminatedHeart Failure With Reduced Ejection FractionChina, Germany, United States, Colombia, Korea, Republic of, Romania, South Africa, Canada, Belgium, Estonia, Hungary, Italy, Russian Federation, Taiwan, Turkey, United Kingdom, Spain, France, Netherlands, Hong Kong, Bulgaria, Israel and more
-
CytokineticsCompletedChronic Heart Failure | Pharmacokinetics | Left Ventricular Systolic Dysfunction | Left Ventricular Ejection Fraction | Modified Release Oral Formulation | History of Chronic Heart Failure | EchocardiogramUnited States, Canada, Italy, Netherlands, United Kingdom, Belgium, Czechia, Australia, Hungary, Poland, Bulgaria, Lithuania, Germany
-
Novo Nordisk A/SCompletedHeart Failure With Preserved Ejection Fraction (HFpEF) and Diabetes Mellitus, Type 2United States, Spain, Hungary, United Kingdom, India, Netherlands, Germany, Japan, Canada, Czechia, Argentina, Austria, Israel, Italy, Poland, Sweden